Objective: to evaluate the clinical value of the Sanya Criteria in the treatment of liver transplantation for hepatocellular carcinoma.
目的：评估“三亚共识”对原发性肝癌肝移植治疗的临床价值。
But although liver transplantation is a recognized therapy for hepatocellular carcinoma, it is not currently offered to those who undergo hepatic resection as the first-line therapy, he notes.
尽管肝脏移植是治疗肝细胞癌的确认疗法，但目前不为首次治疗运用肝切除术的病人提供肝移植术。
Salvage liver transplantation has been performed for recurrent hepatocellular carcinoma (HCC) or deterioration of liver function after primary liver resection.
补救性供肝移植可用于初期行肝切除术后的反复肝细胞癌发生或肝功能恶化。
BACKGROUND: Liver transplantation is an accepted treatment option for patients with otherwise untreatable hepatocellular carcinoma (HCC).
背景：肝移植是对其它方法不可治疗的肝细胞癌（HCC）的一个公认的治疗方法。
The aim of the present study was to compare STACE to conventional TACE in a controlled study of candidates for liver transplantation (LT) for hepatocellular carcinoma (HCC).
本研究的目的是比较常规TACE对照研究肝细胞癌（HCC）肝移植（LT）的候选人灯光音响。
The aim of the present study was to compare STACE to conventional TACE in a controlled study of candidates for liver transplantation (LT) for hepatocellular carcinoma (HCC).
本研究的目的是比较常规TACE对照研究肝细胞癌（HCC）肝移植（LT）的候选人灯光音响。
应用推荐